Leslie D. Funtleyder is CFO at Applied Therapeutics, Inc. (APLT). They have made 13 open-market trades across 1 company since 2020, most recently 2026-02-03.
CIK 0001775394
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| APLT | 152,959 | $16K |
Shares reported on the most recent Form 4, priced at the 2026-02-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| APLT | SELL | 2025-03-04 | 2025-03-06 | $0.44 | $6K | +6.3% | -16.3% | -23.4% |
| APLT | SELL | 2025-02-06 | 2025-02-07 | $0.61 | $14K | -7.3% | -16.0% | -32.8% |
| APLT | SELL | 2024-08-22 | 2024-08-23 | $5.83 | $158K | +0.9% | +32.6% | +60.1% |
| APLT | SELL | 2024-06-06 | 2024-06-10 | $4.32 | $147K | -11.3% | +2.1% | +12.3% |
| APLT | SELL | 2024-03-14 | 2024-03-18 | $5.39 | $310K | +19.3% | -15.3% | -15.3% |
| APLT | SELL | 2020-10-01 | 2020-10-05 | $20.05 | $1.2M | +5.6% | -13.6% | +0.3% |
| APLT | SELL | 2020-08-24 | 2020-08-25 | $23.57 | $790K | -3.9% | -21.4% | -16.5% |
| APLT | SELL | 2020-06-23 | 2020-06-25 | $42.43 | $849K | -14.2% | -31.7% | -45.7% |
| APLT | SELL | 2020-06-18 | 2020-06-22 | $45.32 | $340K | -31.7% | -47.1% | -53.8% |
| APLT | SELL | 2020-06-16 | 2020-06-17 | $44.28 | $421K | -17.4% | -34.2% | -44.3% |
| APLT | SELL | 2020-06-08 | 2020-06-10 | $43.80 | $745K | +15.7% | -27.1% | -41.4% |
| APLT | SELL | 2020-06-02 | 2020-06-04 | $45.03 | $675K | +0.4% | -28.3% | -44.4% |
| APLT | SELL | 2020-05-28 | 2020-06-01 | $45.26 | $835K | -14.3% | -24.2% | -48.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.